Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1986 of 6351
-
New stent graft aims to keep dialysis veins open longer
Disease control CompletedThe purpose of the study is to demonstrate the safety and efficacy of the Merit WRAPSODY Endovascular Stent Graft for treatment of stenosis or occlusion within the dialysis access outflow circuit
Sponsor: Merit Medical Systems, Inc. • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
New hope for kids with rare cancers: targeted drug shows promise
Disease control Recruiting nowThis phase I/II trial studies the effects of trastuzumab deruxtecan (DS-8201a) in treating patients with osteosarcoma, Wilms tumor (WT) or desmoplastic small round cell tumor (DSRCT) that is newly diagnosed or has come back after a period of improvement (recurrent) or that has no…
Phase 2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Sep 10, 2026 00:00 UTC
-
Could a drug speed recovery from Guillain-Barré syndrome?
Disease control CompletedThis is a Phase 3, prospective, multicenter, placebo controlled, double blind, randomized study to investigate the efficacy and safety of eculizumab in participants with severe GBS, defined using the Hughes Functional Grade (FG) scale as progressively deteriorating FG3 or FG4/FG5…
Phase 3 • Sponsor: Alexion Pharmaceuticals, Inc. • Aim: Disease control
Last updated Jun 26, 2026 14:47 UTC
-
Triple-Drug cocktail shows promise in Hard-to-Treat cancers
Disease control CompletedThis is a single-centre, phase 1a (dose escalation) and 1b (dose expansion) study to evaluate the safety and tolerability of oral Selinexor in combination with nivolumab and ipilimumab in patients with advanced solid malignancies.
Phase 1 • Sponsor: National University Hospital, Singapore • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
Targeted radiation may extend life quality in breast cancer that has spread
Disease control CompletedThe prognosis for patients with metastatic breast cancer has improved continuously. Systemic therapies alone are not able to cure the disease permanently. Investigators initiated this randomized controlled multinational and multicenter clinical trial to analyse the impact of a l…
Sponsor: University Hospital Schleswig-Holstein • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC
-
Could a common heartburn pill boost chemo against tough prostate cancer?
Disease control Recruiting nowThe purpose of this research study is to find out what effects (good and bad) omeprazole and cabazitaxel, or omeprazole and docetaxel, has on participants and their condition. Investigators believe omeprazole may help the other medications work.
Phase 2 • Sponsor: Wake Forest University Health Sciences • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
New drug shows promise for rare muscle disease in kids
Disease control CompletedThis is a randomized, multicenter, double-blind, placebo-controlled, Phase 2/3 study of patients (aged 6 to 16 years) diagnosed with Congenital Myotonic Dystrophy (Congenital DM1).
Phase 2/3 • Sponsor: AMO Pharma Limited • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC
-
New drug cocktail aims to shrink Hard-to-Treat melanoma
Disease control Recruiting nowThis phase II trial studies how well binimetinib and imatinib work in treating patients with stage III-IV KIT-mutant melanoma that cannot be removed by surgery (unresectable). Binimetinib and imatinib may stop the growth of tumor cells by blocking some of the enzymes needed for c…
Phase 2 • Sponsor: University of California, San Francisco • Aim: Disease control
Last updated Aug 20, 2026 00:00 UTC
-
Could a simple pill keep relapsed testicular cancer at bay?
Disease control Recruiting nowThis is an open label randomized phase II trial of maintenance oral etoposide vs. observation in patinets with relapsed GCT treated with high-dose chemotherapy (HDCT) and peripheral-blood stem-cell transplant (PBSCT).
Phase 2 • Sponsor: Nabil Adra • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC
-
Can we predict who recovers bowel and bladder control after rectal surgery?
Knowledge-focused Recruiting nowThe aim of this study is the systematic analysis of the development of perioperative rectal and urogenital function in patients undergoing rectal resection with total mesorectal excision and the identification of risk factors for urogenital and sphincter function loss after this …
Sponsor: Technische Universität Dresden • Aim: Knowledge-focused
Last updated Aug 29, 2026 00:00 UTC
-
Shorter steroid course may be just as effective for giant cell arteritis
Disease control Recruiting nowCorticosteroid therapy has always been the standard treatment for giant cell arteritis (GCA), with very good initial clinical efficacy but a high relapse rate when it declines. The target population of this condition, often elderly, is particularly exposed to the numerous undesi…
Phase 3 • Sponsor: University Hospital, Caen • Aim: Disease control
Last updated Jun 28, 2026 00:00 UTC
-
Glowing dye may help surgeons spot hidden cancer cells during sarcoma removal
Knowledge-focused Recruiting nowTumor margin confirmation is important to confirming appropriate disease excision. Current standard of care is to take select margin samples to pathology for intra-operative readings. However, this is expensive, time consuming, and only assesses the margin contained within the sp…
Phase 2 • Sponsor: Kurt Weiss • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:06 UTC
-
Firefighters' lungs under the scanner: new study aims to catch cancer early
Knowledge-focused CompletedThis study will evaluate whether LDCT findings differ between firefighters and non-fighters, the relationship between occupational exposures and LDCT findings, and whether a proteomics assay can further risk-stratify screen-detected nodules among a study population of 850 current…
Sponsor: Massachusetts General Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:59 UTC
-
New antibody drug takes aim at Hard-to-Treat lymphoma
Disease control OngoingThis phase 1 study will investigate the safety, tolerability, pharmacokinetic, pharmacodynamic, and clinical activity of AZD0486, a CD19 x CD3 T-cell engaging bispecific antibody, in subjects with B-cell non-Hodgkin lymphoma (B-NHL).
Phase 1 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Bionic leg feedback: can a neuroprosthesis bring back sensation for amputees?
Disease control OngoingThe purpose of this study is to evaluate the effectiveness of providing sensation of the missing limb to individuals with above and below the knee limb loss. The investigators will implanted stimulating electrodes to send small electrical currents to the remaining nerves. These s…
Sponsor: VA Office of Research and Development • Aim: Disease control
Last updated Aug 22, 2026 00:00 UTC
-
Coffee as medicine? major trial tests caffeine against Alzheimer's
Symptom relief Recruiting nowSporadic Alzheimer's disease is a multifactorial illness arising a major medico-economic stakes for our aging societies. There is currently no curative treatment available. Coffee is a complex beverage with psychostimulant properties whose main effective element, caffeine, has a…
Phase 3 • Sponsor: University Hospital, Lille • Aim: Symptom relief
Last updated Jun 27, 2026 12:10 UTC
-
New program aims to boost treatment adherence in black breast cancer survivors
Disease control OngoingThe purpose of this study is to test an evidence-based intervention designed to increase adherence to systemic therapy in Black women compared to enhanced usual care.
Sponsor: Virginia Commonwealth University • Aim: Disease control
Last updated Aug 28, 2026 00:00 UTC
-
Acupuncture needles take on Chemo's nerve damage
Symptom relief CompletedThis three-armed, multicenter, randomized, parallel, sham-controlled clinical trial will conduct in three centers in Taiwan. The investigators will randomly assign 234 eligible patients into three groups, an acupuncture group (n=90), a sham-controlled group (n=90), and a waitlist…
Sponsor: Taiwan Municipal An-Nan Hospital-China Medical University • Aim: Symptom relief
Last updated Jul 15, 2026 00:00 UTC
-
Can a Once-Daily cream tame psoriasis in toddlers?
Disease control CompletedThis is a Phase 2, open label, maximal usage PK and safety study of ARQ-151 cream 0.3% in pediatric subjects (ages 2 to 5 years old) with plaque psoriasis:
Phase 2 • Sponsor: Arcutis Biotherapeutics, Inc. • Aim: Disease control
Last updated Aug 09, 2026 00:00 UTC
-
Own stem cells may heal scarred vocal cords and restore voice
Disease control CompletedThe overall aim of the project is to develop a new method for treatment of untreatable severe hoarseness due to vocal fold scarring by local injection of autologous mesenchymal stromal cells (MSC). At present there is no lasting effective treatment for this condition which result…
Phase 1/2 • Sponsor: Karolinska University Hospital • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC